PLANO, Texas–(BUSINESS WIRE)–Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a clinical-stage…
— NUZYRA® (omadacycline) Generated Net U.S. Sales of $14.9 Million from the Core Commercial Business, a 13% Increase over the…
RESEARCH TRIANGLE PARK, N.C., Aug. 09, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced today…
GERMANTOWN, Md., Aug. 9, 2021 /PRNewswire/ — Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the…
Ballard Power reported improved earnings results for Q2, but near-term prospects remain bleak. Read why I think investors should…
By Tom Konrad, Ph.D., CFA Second quarter earnings season is in full swing. Below are a couple updates and the monthly performance…
TSN earnings call for the period ending July 3, 2021.
RadNet, Inc. (NASDAQ:RDNT) Q2 2021 Earnings Conference Call August 9, 2021 10:30 AM ETCompany ParticipantsMark Stolper – Executive…
Ebix, Inc. (NASDAQ:EBIX) Q2 2021 Results Conference Call August 9, 2021 11:00 AM ETCompany ParticipantsRobin Raina – Chairman,…
Boot Barn reported Q1 2022 results last week, and it saw a massive beat on both revenue and quarterly earnings per share. The…